Hjem › Sigdcelleanemi › Texas › Houston
Kliniske studier for Sigdcelleanemi i Houston, TX
10 studier for Sigdcelleanemi søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruttererFase 3
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
RekruttererFase 3
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RekruttererFase 3
- UT Health University of Texas, Houston
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- UT Health Science Center, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RekruttererObservasjonsstudie
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
RekruttererFase 3
- Baylor College of Medicine- Site Number : 8400055, Houston
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
RekruttererObservasjonsstudie
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
RekruttererFase 3
- Site # 8400004, Houston
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
RekruttererFase 2
- Baylor College of Medicine, Houston
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
RekruttererObservasjonsstudie
- University of Texas at Houston, Houston
Sigdcelleanemi-studier i andre byer
- Atlanta, GA22 studier
- Washington, DC20 studier
- Memphis, TN18 studier
- Chicago, IL18 studier
- Philadelphia, PA15 studier
- Birmingham, AL14 studier
- New York City, NY13 studier
- St. Louis, MO12 studier
- Durham, NC10 studier
- Cincinnati, OH10 studier
- Boston, MA10 studier
- Pittsburgh, PA9 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.